Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Laekna's LAE102 Delivers Promising Weight Loss With Lean Mass Gains in Completed 24‑Week Low‑Dose Monotherapy Cohorts – Selective ActRIIA Antibody Well Tolerated, High‑Dose Cohort Fully Enrolled
CompanyDrug

Laekna’s LAE102 Delivers Promising Weight Loss With Lean Mass Gains in Completed 24‑Week Low‑Dose Monotherapy Cohorts – Selective ActRIIA Antibody Well Tolerated, High‑Dose Cohort Fully Enrolled

Laekna, Inc. (HKG: 2105) announced, in a voluntary business update, that the Group has completed treatment in the low‑dose cohorts of the 24‑week monotherapy study of LAE102, its internally discovered…

CARsgen Doses First Patient in Registrational Phase I Trial of CT0596 – Allogeneic BCMA CAR‑T Built on THANK‑u Plus® Platform Advances Toward Relapsed/Refractory Multiple Myeloma

CARsgen Doses First Patient in Registrational Phase I Trial of CT0596 – Allogeneic BCMA CAR‑T Built on THANK‑u Plus® Platform Advances Toward Relapsed/Refractory Multiple Myeloma

Wantai/Innovax Receives NMPA Clinical Trial Approval for Lyophilized Recombinant RSV Vaccine (CHO Cell) – Adjuvant‑Free Pre‑F Protein Candidate Targets Adults Aged 60 and Above

Wantai/Innovax Receives NMPA Clinical Trial Approval for Lyophilized Recombinant RSV Vaccine (CHO Cell) – Adjuvant‑Free Pre‑F Protein Candidate Targets Adults Aged 60 and Above

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

CSPC Receives CDE Approval for Generic Version of Pfizer’s Xeljanz

CompanyDrug

Henlius Biotech’s Hanbeitai Approved for Hepatocellular Carcinoma

CompanyDrug

Antengene’s Xpovio Receives Taiwan FDA Approval for Multiple Indications

CompanyDrug

Frontier Biotechnologies Secures Approval for HIV Therapy Alfusid

CompanyDrug

China Approves GSK’s Juluca for HIV-1 Infection

CompanyDrug

Hainan Poly Pharm’s Generic Ganciclovir Approved in Sweden for CMV Retinitis

CompanyDrug

YiChang HEC ChangJiang Pharma’s Insulin Aspart Gains NMPA Approval

CompanyDrug

Henlius Biotech’s Hanbeitai Gains NMPA Approval for Recurrent Glioblastoma

Show More